Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Uncategorized
Uncategorized
Random
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Materials Manager
atai Life Sciences to Participate in Upcoming June Investor Conferences
atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT
The Psilocybin Supply Chain: An Evidence-Based Review
November 2020 Newsletter
atai Life Sciences Announces Results from the Kures Therapeutics Phase 1...
atai Life Sciences Reports Second Quarter 2022 Financial Results & Business...
Psychedelic Guides with Ketan Patel of Next Healthcare Technologies Inc
Psychedelics Versus Cannabis: Exploring their Impact on Treating Mental Illness
atai Life Sciences to Host Conference Call and Webcast to Discuss...
atai Life Sciences Announces Positive Initial Results for Phase 1 Trial...
The atai Fellowship Fund in Psychedelic Neuroscience Announces its First Cohort...
atai Life Sciences Announces First Subject Dosed in Phase 1 Trial...
Feb 10: $SPOR +40.91%, $PSYC +35.42%, $MCUR +23.33%
atai Life Sciences Announces Initiation of Phase 1 Proof-of-Concept Clinical Trial...
1
2
3
...
12
Page 1 of 12